INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Intercure Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$4.46−0.11 (-2.41%)
Close on Oct 19, 2026
Share price
−$3.49 (−43.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Intercure Ltd. grew revenue 13.1% to 270.20M ILS over fiscal 2025. Free cash flow was 13.29M ILS.
Revenue
270.20M ILS
+13.1% vs. a year earlier
Operating income
-27.24M ILS
FY2025
Free cash flow
13.29M ILS
FY2025
EPS, diluted
-0.66 ILS
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- 270.20M ILS
- Net income
- -35.71M ILS
- EPS, diluted
- -0.66 ILS
- Free cash flow
- 13.29M ILS
Valuation needs the share price. It fills in once daily prices are connected and converted from ILS.
Eight years at a glance
Fiscal years 2018 to 2025, ILS
Revenue
270.20M ILS+13.1% YoY
Gross profit
33.18M ILS+9.8% YoY
Operating income
-27.24M ILS
Net income
-35.71M ILS
EPS, diluted
-0.66 ILS
Free cash flow
13.29M ILS
Reported period